Cabergoline Tablet
Product Images NDC 50742-118

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 50742-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F39485b0 F641 41ab B35f 3b002f76c14d 01

Chemical structure of the active ingredient Cabergoline, showing its molecular configuration with various functional groups and ring systems visible in the diagram.*

FDA Label Image

F39485b0 F641 41ab B35f 3b002f76c14d 02

FDA Label Image

F39485b0 F641 41ab B35f 3b002f76c14d 03

Label for Cabergoline Tablets, USP 0.5 mg by Ingenus Pharmaceuticals, LLC. The label states the product contains 8 tablets, with storage instructions at 20° to 25°C (68° to 77°F). It includes warnings to keep the drug out of reach of children and to dispense in the original container. Manufactured for Ingenus Pharmaceuticals, made in India, with NDC 50742-118.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.